Abstract
Fifty-three patients, 2 to 18 years old with histologically proven non-Hodgkin's lymphoma (NHL) were treated with combined chemotherapy and involved or extended field irradiation between 1975 and 1982. The disease was classified as undifferentiated Burkitt's type (24), large cell (histiocytic) type (12), lymphoblastic type (13), and undifferentiated non-Burkitt's type (4). Doses of radiation ranged from 1500 to 4000 cGy with an average of 3000 cGy. Disease-free survival at 2 years was: large cell type 9 out of 12 (75%), lymphoblastic 6/13 (46%), undifferentiated non-Burkitt's 1/4 (25%), and Burkitt's lymphoma 12/24 (50%). Bone marrow and/or cerebrospinal fluid relapses continue to be major roadblocks to the successful treatment of childhood non-Hodgkin's lymphoma. Improved success in treatment will depend upon the development of better strategies designed to prevent the occurrence or recurrence of central nervous system (CNS) lymphoma and of more effective systemic therapy. The potential role of radiation...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
